Profile data is unavailable for this security.
About the company
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
- Revenue in USD (TTM)5.64m
- Net income in USD-23.88m
- Incorporated1999
- Employees141.00
- LocationEvogene Ltd13 Gad Feinstein Street, Park RehovotREHOVOT 7638517IsraelISR
- Phone+972 89311900
- Fax+972 89466724
- Websitehttps://evogene.com/
| Holder | Shares | % Held |
|---|---|---|
| SilverArc Capital Management LLCas of 31 Dec 2023 | 3.10m | 6.13% |
| Meitav Mutual Funds Ltd.as of 29 Feb 2024 | 362.81k | 0.72% |
| Walleye Capital LLCas of 31 Dec 2023 | 349.48k | 0.69% |
| KSM Mutual Funds Ltd.as of 29 Feb 2024 | 276.61k | 0.55% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 186.97k | 0.37% |
| Migdal Mutual Funds Ltd.as of 29 Feb 2024 | 145.25k | 0.29% |
| P&S Verm�gensberatungs AG Performance & Sicherheitas of 31 Jan 2024 | 100.00k | 0.20% |
| LPL Financial LLCas of 31 Dec 2023 | 66.84k | 0.13% |
| JPMorgan Securities LLC (Investment Management)as of 31 Dec 2023 | 64.59k | 0.13% |
| Geode Capital Management LLCas of 31 Mar 2024 | 59.01k | 0.12% |
